8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Clorox reports lower FY26 sales and EPS, forecasts growth for FY27
Filed with the SEC on · Summarized by InvestorsBot
Clorox’s fourth-quarter net sales fell 2% to $1.95 billion and diluted EPS dropped 50% to $1.34, while fiscal 2026 sales declined 5% to $6.72 billion and diluted EPS fell 26% to $4.81. The company completed its acquisition of GOJO Industries on April 1, 2026, and expects fiscal 2027 sales to rise 13% to 14%, organic sales to grow 3.5% to 4.5%, and adjusted EPS to reach $5.70 to $6.00, including about $46 million in GOJO-related costs.